Most of the questions below reached us in some form from people in your position: a spouse, an adult child, a parent who has managed somebody else's depression long enough to know the medication list by heart.
The answers lean on our June 2026 polling of 443 adults, all from the Midwest, spread over ten states, plus the plain regulatory facts about how these treatments are delivered. Where the honest answer is "it depends on your plan" or "ask the clinician," that is what you will get.
Do people actually want to go somewhere for this, or do they want it at home?
We asked respondents where they would prefer to get ketamine or esketamine therapy. The clinic won outright at 44 percent. The pure at-home telehealth option and the start-in-clinic, continue-at-home hybrid came in at 22 and 23 percent, while a small 11 percent did not mind. The panel data behind these numbers is validated.
Can the FDA-approved version be done at home?
No. Esketamine, the medicine sold as Spravato, carries approval for depression that other treatment could not budge, and every dose happens inside a certified clinic, with staff watching the patient afterward. No one can arrange delivery to a living room. If you want to see what the supervised version involves, Brain Recovery Centers walks through the steps of a Spravato visit.
The at-home services you see advertised prescribe generic ketamine off label, usually as a lozenge or dissolving tablet, after a telehealth visit. That is a legally and clinically different arrangement. Keep the two apart.
Why does that distinction matter so much to a family?
Because nearly everything practical flows from it: where you drive, what a plan will consider paying for, who watches the person during a dose, what happens if a session goes badly, and whom you call at 8 p.m. on a Sunday.
Who should we call first?
The survey is blunt. If they wanted this treatment, 56 percent of respondents would see their family physician first and 23 percent a psychiatrist or counselor; only 12 percent would search online, and 5 percent could not say where they would begin.
Start with the doctor who already knows the person. That visit produces the referral and, just as important, the documented medication history everything downstream depends on.
What should I bring to that appointment?
One page: every antidepressant tried, rough dates, how long each lasted, and why it stopped, plus a concrete picture of the last month, such as sleep, missed work, appetite, and whether they leave the house. Ask the office to list you as an authorized contact if the person consents, or nobody will be allowed to tell you anything.
He says he does not want to hear about it from me. What now?
Then stop being the one who makes the case. Among our respondents, the likeliest thing to get them to try this was their own doctor recommending it, at 74 percent. Friends and relatives trailed far behind at 18 percent, and ads at 2. Your leverage is getting him into the exam room with an accurate history, not winning at the kitchen table.
What kind of insurance do people in this market actually have?
Respondents could pick every payer that applied. Commercial insurance led with 39 percent and Medicaid followed closely at 37; Medicare accounted for 23 percent, no insurance for 9, and TRICARE for 5, while 2 percent kept it private.
A clinic that takes only commercial plans leaves much of the region out.
How much does coverage drive the decision?
Heavily. Of every attribute we tested, insurance was the one respondents most often placed in their top two, at 85 percent. Proximity landed second at 43 percent; FDA approval had 27 and fast results 24; privacy had 11 and a service-member specialty 10.
How long is a visit and can he drive himself?
A supervised dosing visit includes a monitoring period afterward, and the patient may not drive after the session. Ask each clinic for the real door-to-door duration and the visit frequency during the first month, then check it against your own schedule before anyone commits. Whether you are coming from O'Fallon, Lake St. Louis, or farther west, the drive is usually the smaller half of the time cost; the monitoring window is the larger.
My family is military connected. Does that change anything?
It changes whom you call and what paperwork exists, not what the treatment is. TRICARE showed up in 5 percent of our sample's payer answers. In the same sample, 29 percent described themselves as a parent or relative of a veteran or first responder, and about 7 percent were veterans, active military, or first responders themselves.
If TRICARE is the plan, ask the primary provider how a referral works under it.
Is skepticism about this treatment unusual?
Not at all. Our first-reaction question found cautious but open the largest group at 34 percent, hopeful or curious at 18, skeptical at 21, unfamiliar at 18, and negative at 9. Roughly half the room is open and fewer than one in ten firmly opposed.
What is the one thing to do this week?
Build the medication page and book the appointment. Everything else, clinic versus home included, flows from a clinician's assessment, and trying to shortcut that step wastes weeks.
An important limit on all of this
None of this is medical advice, and no survey can decide what suits a particular person. Esketamine is approved for a specific condition and given under supervision; at-home ketamine is off label with variable oversight; both carry considerations only a clinician reviewing a full history can weigh. Be wary of anyone who offers certainty without one.
Finally, please hold on to this. If the person you look after starts talking about not being here, or you fear for their safety tonight, dial or text 988; the Lifeline picks up day or night, nationwide. Caregivers may call about someone else, and calling early beats waiting to be sure.
Methodology
These survey figures come from research this publisher commissioned and funded. Pollfish ran it on its consumer panel; when fieldwork ended June 23, 2026, the questionnaire had been completed by 443 consenting adults between 18 and 64 from ten Midwest states. Several questions allowed more than one answer, so those results total over 100. The panel has finished validating the data.